Warrants (Number of Warrants, Exercise Price, Aggregate Proceeds of Warrants if Exercised) (Details)	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	1,209,649
Shares, Issuances | shares	170,000
Shares, Balance at March 31, 2016 | shares	1,379,649
Aggregate proceeds if exercised | $	$ 12,881,016
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 8.96
Weighted Average Exercise Price, Issuances | $ / shares	12.00
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 9.34
Novolytics Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares
Shares, Issuances | shares	170,000
Shares, Exercises | shares
Shares, Balance at March 31, 2016 | shares	170,000
Aggregate proceeds if exercised | $	$ 2,040,000
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares
Weighted Average Exercise Price, Issuances | $ / shares	$ 12.00
Weighted Average Exercise Price, Exercises | $ / shares
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 12.00
Warrants Through March 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	488,484
Shares, Balance at March 31, 2016 | shares	488,484
Aggregate proceeds if exercised | $	$ 5,251,203
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 10.75
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 10.75
2013 Series B Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	467,046
Shares, Balance at March 31, 2016 | shares	467,046
Aggregate proceeds if exercised | $	$ 3,269,322
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 7.00
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 7.00
Warrants Through December 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	86,408
Shares, Balance at March 31, 2016 | shares	86,408
Aggregate proceeds if exercised | $	$ 712,866
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 8.25
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 8.25
Convertible Promissory Notes [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	140,608
Shares, Balance at March 31, 2016 | shares	140,608
Aggregate proceeds if exercised | $	$ 984,256
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 7.00
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 7.00
Warrants Through 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance at December 31, 2015 | shares	27,103
Shares, Balance at March 31, 2016 | shares	27,103
Aggregate proceeds if exercised | $	$ 623,369
Weighted Average Exercise Price, Outstanding at December 31, 2015 | $ / shares	$ 23.00
Weighted Average Exercise Price, Outstanding at March 31, 2016 | $ / shares	$ 23.00